Approval · Notice of Compliance 17337 · 2015
ERBITUX: Notice of Compliance 17337
Issued October 1, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17337
- Date
- October 1, 2015
- Company
- Imclone LlcBranchburg, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling changes, new canadian distributor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERBITUX | Not yet assigned | — |
Medicinal ingredients
- CETUXIMAB 2 MG per ML